TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
QGEN

Qiagen NV

Healthcare · Diagnostics & Research

44.20$ -0.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow QGEN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
21.4% 24.8% 25.5% 20.2% 23.9% 21.7% 26.3% 28.4% 33.4% 23.4% 34.0% 31.3%
14.9% 14.9% 15.9% 15.3% 13.7% 15.2% 11.2% 9.5% 9.7% 10.4% 10.3% 9.3%
3.1% 2.2% 2.1% 2.4% 2.7% 4.3% 2.2% 1.7% 2.3% 2.4% 2.2% 2.4%
1.2% 0.3% 1.4% 6.6% 1.5% 9.5% -4.1% 1.8% -4.4% – – –
-5.9% -6.3% 0.8% -4.7% -6.3% -2.9% 0.9% -5.8% -1.5% -9.5% 6.8% -1.7%
7.2% 9.2% 7.0% 8.8% 10.0% 18.0% 16.3% 9.2% 7.0% 8.3% 8.5% 9.6%
-30.3% -11.4% -13.4% -32.8% -14.1% -14.6% -23.7% -9.0% -33.9% -4.5% -12.6% -14.6%
58.4% – – 54.3% 37.8% – 33.3% – 1.2% 0.0% 0.0% 2.6%
-9.4% -1.6% 0.0% -4.3% -7.0% -4.9% -3.4% -4.4% -1.2% -0.9% -14.8% -14.7%
24.2% -19.7% -0.6% 51.0% 32.9% -41.9% -1.9% -1.8% -6.3% -22.2% -5.4% 10.0%
14.3% -20.2% -0.8% 27.3% 24.0% -41.9% -4.0% -6.7% -5.9% -22.1% -21.4% -8.6%
4.6% -8.0% 11.1% 15.4% 33.4% -34.7% -1.7% 12.5% -7.0% -3.2% -0.2% 8.4%
14.2% 15.6% 18.5% 11.5% 13.9% 3.7% 10.1% 19.2% 26.4% 15.1% 25.6% 21.7%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?